Partnerships with patients’ organisations

The ILDS is committed to the inclusion of the patient voice in our work and we collaborate with patients’ organisations across a range of areas.

One of our objectives in the ILDS 2020-2023 Strategy is to develop a framework for meaningful and systematic engagement and collaboration between the ILDS and patients’ organisations and patient leaders.

The ILDS Patients’ Organisations Working Group was set up in 2020 and its overarching goals for 2020-2023 are to ensure that the patients’ voice is considered in ILDS activities and to foster dialogue and partnerships between the ILDS, its Members, and patients’ organisations to improve access to dermatological patient-centred healthcare worldwide.

We will do this by following the strategic approaches outlined below:

  • fostering exchange between patients’ organisations, health providers and policy-makers in the development of skin health policies and services,
  • building strategic alliances with key patients’ organisations in order to identify and collaborate on areas of mutual interest,
  • nurturing and supporting patient engagement to improve the knowledge and understanding of the burden of skin diseases, patients’ unmet needs, and patients’ essential role and perspectives among stakeholders, including policy-makers.

Current collaborations with patients’ organisations

The ILDS is currently working with patients’ organisations in the following areas:

World Congress of Dermatology
Patient involvement is an important aspect of the World Congress of Dermatology. Read about involvement in previous congresses here. In 2023, the opportunity for patients to participate in and have their voice heard within the World Congress of Dermatology will be a priority for the ILDS and supported by a clear framework with a range of opportunities for patient engagement. We invite patients’ organisations interested in having an exhibition booth at the 25th World Congress of Dermatology in Singapore, 3-7 July 2023, to contact us to express their interest on

Alongside this, we will be actively engage patients’ organisations in the development of the Congress Scientific Programme. The WCD is an ideal opportunity for the inclusion of patients’ experiences as “disease experts” and as leaders in the dermatology community.

Global Psoriasis Atlas
The ILDS is working in collaboration with the International Federation of Psoriasis Associations (IFPA) on the Global Psoriasis Atlas. The Global Psoriasis Atlas (GPA) is the leading epidemiological web-based resource on psoriasis globally; thus informing research, policy and heath care provision for the disease worldwide. The ILDS has being collaborating with IFPA for a number of years and supported IFPA’s successful advocacy for psoriasis to be put on the global health agenda through its adoption as a WHO resolution (in 2014).

International Alliance of Dermatology Patient Organizations (IADPO)
ILDS was there at the inception of IADPO and has followed its impressive growth and development. Through frequent communication and dialogue since 2015, areas of common interest have been identified and a supportive collaboration has been established. There has been reciprocal involvement in activities such as conferences, issue specific webinars and strategy meetings. In 2020, we will continue to build on this foundation through the development of a Memorandum of Understanding and collaboration on specific projects including the World Congress of Dermatology.

Information and Support*


The ILDS does not produce treatment information for patients. Below are links to patient resources that have been developed by ILDS Members.

*The ILDS does not endorse or verify any of the content on these websites.